CVS Health
company
CVS NYSE
ISIN US1266501006 SEC CIK 64803 LEI 549300EJG376EN5NQE29
Follow CVS Health
Weekly email: filings, results
Revenue, last quarter
$108.4B
+5.4% vs same quarter last year
Net income
$2.2B
+154.6% vs same quarter last year
EPS, diluted
$1.68
+153.7% vs same quarter last year
Operating cash flow
$4.7B
+493.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $402.1B | $1.8B |
| FY24 | $372.8B | $4.6B |
| FY23 | $357.8B | $8.3B |
| FY22 | $322.5B | $4.3B |
| FY21 | $292.1B | $8B |
| FY20 | $268.7B | $7.2B |
| FY19 | $256.8B | $6.6B |
| FY18 | $193.9B | −$594M |
| FY17 | $184.8B | $6.6B |
| FY16 | $177.5B | $5.3B |
| FY15 | $153.3B | $5.2B |
| FY14 | $139.4B | $4.6B |
| FY13 | $126.8B | $4.6B |
| FY12 | $123.1B | $3.9B |
| FY11 | $107.1B | $3.5B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 45% | 1.2% | 0.4% |
| FY24 | 44.7% | 2.3% | 1.2% |
| FY23 | 39.3% | 3.8% | 2.3% |
| FY22 | 38.9% | 2.5% | 1.3% |
| FY21 | 39.8% | 4.6% | 2.7% |
| FY20 | 39% | 5.2% | 2.7% |
| FY19 | 38.2% | 4.7% | 2.6% |
| FY18 | 19.3% | 2.1% | −0.3% |
| FY17 | 15.4% | 5.2% | 3.6% |
| FY16 | 16.3% | 5.9% | 3% |
| FY15 | 17.3% | 6.2% | 3.4% |
| FY14 | 18.2% | 6.3% | 3.3% |
| FY13 | 18.8% | 6.3% | 3.6% |
| FY12 | 18.3% | 5.9% | 3.1% |
| FY11 | 19.2% | 5.9% | 3.2% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $7.8B |
| FY24 | $6.3B |
| FY23 | $10.4B |
| FY22 | $13.5B |
| FY21 | $15.7B |
| FY20 | $13.4B |
| FY19 | $10.4B |
| FY18 | $6.8B |
| FY17 | $6.1B |
| FY16 | $7.9B |
| FY15 | $6.2B |
| FY14 | $6B |
| FY13 | $3.8B |
| FY12 | $4.6B |
| FY11 | $4B |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $3.4B | $0 |
| FY24 | $3.4B | $3B |
| FY23 | $3.1B | $2B |
| FY22 | $2.9B | $3.5B |
| FY21 | $2.6B | $0 |
| FY20 | $2.6B | $0 |
| FY19 | $2.6B | $0 |
| FY18 | $2B | $0 |
| FY17 | $2B | $4.4B |
| FY16 | $1.8B | $4.5B |
| FY15 | $1.6B | $5B |
| FY14 | $1.3B | $4B |
| FY13 | $1.1B | $4B |
| FY12 | $829M | $4.3B |
| FY11 | $674M | $3B |
- CVS Health
- Consumer median
Show the numbers
| Year | CVS Health | Consumer median |
|---|---|---|
| FY25 | 0.4% | 1.1% |
| FY24 | 1.2% | 1.5% |
| FY23 | 2.3% | 2.1% |
| FY22 | 1.3% | 2.5% |
| FY21 | 2.7% | 2.5% |
| FY20 | 2.7% | 1.8% |
| FY19 | 2.6% | 2.6% |
| FY18 | −0.3% | 3.8% |
| FY17 | 3.6% | 3.8% |
| FY16 | 3% | 4.3% |
| FY15 | 3.4% | 3.8% |
| FY14 | 3.3% | 3.6% |
| FY13 | 3.6% | 3.9% |
| FY12 | 3.1% | 4.1% |
| FY11 | 3.2% | 2.9% |